Dr. Daniel B. Cox, MD
General Surgery (Surgery Physician)
- Medicare participating
At a glance
- Medical school
- University of Alabama School of Medicine (2005)
- Years since graduation
- 21
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 128
Licensed in Alabama since 2007, according to the Alabama Board of Medical Examiners and Medical Licensure Commission. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Medical school: University of Alabama School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Surgery Physician primary
AL license 27784 (first issued 2007; active) - Student in an Organized Health Care Education/Training Program
-
Surgical Critical Care Physician
OH license 35.099572
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Alabama Hospital Birmingham, AL
- Riverview Regional Medical Center Gadsden, AL
Medical groups
- University of Alabama Health Services Foundation, PC (2,814 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 128
- Services billed
- 300
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Critical care, first 30-74 minutes | 108 | 57 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 44 | 28 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 25 | 18 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 24 | 24 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 12 | 12 |
| Insertion of needle into vein (3 years or older) | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Isosorbide Mononitrate Er (isosorbide mononitrate) Other prescribers in Birmingham, AL | 12 |
| Eliquis (apixaban) Other prescribers in Birmingham, AL | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $19.85 in total to this clinician.
| Davol Inc. | $19.85 |
|---|
| Food and Beverage | $19.85 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $31,476 in research payments for these studies, mostly to the institutions running them.
- Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study )
Csl Behring · Terminated · NCT05568888
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.